Six Sun Pharma Eye Drop Brands Recalled; Distributors Asked to Return Stocks
What Happened
Sun Pharma has withdrawn six major prescription eye-drop brands, including Nepalact OD, Nepalact, Nepalact-Z, Lotepred T, Lotepred LS and Lotepred 1%, from the Indian market as a "precautionary measure." Distributors have been instructed to stop billing the products and return existing stocks. The company has not publicly disclosed the exact reason for the recall. However, multiple reports have linked the move to potential contamination concerns.
Key Takeaways
Sun Pharma's precautionary recall of widely used eye drops has raised concerns over potential quality issues, although the company has not confirmed the cause.